Increasing tariffs and trade policies are driving up prices for cannabis accessories, impacting consumers who face strategic price hikes disguised as inflation. Major corporations pass these costs to customers while small producers struggle. The industry’s silence on these issues highlights economic manipulation, urging consumers to support local brands and demand transparency.
Tommy Chong Returns to Raise Hell at Hash Bash
The Ann Arbor Hash Bash, held annually since 1972, symbolizes the ongoing fight for cannabis rights and culture. Headlined by Tommy Chong in 2025, it embodies protest and celebration against restrictive drug laws. The event attracts diverse generations, emphasizing the fight for freedom and autonomy amid the commercialization of cannabis culture.
Pot Culture Magazine’s April 2025 Cover: A Culture at a Crossroads
Cannabis culture is at a turning point. This month's cover reflects the tension—progress on one side, resistance on the other. As legalization faces a new wave of scrutiny and misinformation, the future isn’t guaranteed. It’s being shaped now, by the people paying attention.
BREAKING: DEA Reclassifies Marijuana as a Vegetable
In a bizarre twist of bureaucratic brilliance, the DEA has reclassified marijuana as a leafy green vegetable—officially adding it to the American food pyramid. From salad bowls to school lunches, the War on Drugs just got edible. Satirical? Yes. Unbelievable? Barely.
Build Fast, Die Loud: Why Big Weed Keeps Going Bust in California
Gold Flora’s implosion wasn’t a one-off—it was a warning. From ballooned budgets to influencer-backed ego trips, Big Weed’s collapse in California shows what happens when hype and hubris replace substance and sustainability. We break it all down and expose how the industry got too loud, too fast, and now can’t afford the silence.
The DEA’s Stance on Rescheduling: Progress or Stalemate?
The DEA is delaying the rescheduling of marijuana from Schedule I, despite overwhelming scientific support and recommendations from health authorities. This stalling harms the cannabis industry, patients, and communities affected by marijuana criminalization. Political influences from big pharmaceutical companies contribute to this resistance, prolonging the adverse effects of current drug policies.